Sermorelin + GHRP-2: evidence and reported use
Medically reviewed by the Rite Aid Health Team · Last updated August 14, 2026
Sermorelin and GHRP-2 are paired to create a growth-hormone pulse through a releasing-hormone receptor and a ghrelin receptor. People usually discuss the pair for sleep, recovery, or body composition. GHRP-2 also brings appetite, cortisol, and prolactin questions that shape the comparison.
Get the Free Peptide Tracking Toolkit
Sermorelin + GHRP-2 + many more
Explore the guide, then keep the details you verify in the Excel workbook.
Excel workbook
11 worksheets for vials, schedules, labs, storage, and more.
PDF guide
Review providers, products, documents, storage, and travel.
Free download
Useful before or after you start
- Before you start, compare the details that matter and build a focused question list.
- Already using peptides? Keep vials, administration, sites, wellness notes, labs, storage, and travel together.
- Separate your schedule from what actually happened, so important dates are easier to spot.
- Keep your private working copy on your own device.
Confirm your email to receive both downloads and your personal 20% off coupon.
Almost done
We sent the first email to .
Confirm your email to get the toolkit and your 20% off coupon.
We also sent a verification text. Reply YES to confirm your phone number.
-
1
Confirm your email
Open the first email and click the confirmation link.
-
2
Only after step 1
Then the toolkit arrives
We email your Excel workbook and PDF guide right away. Your personal 20% off coupon follows when ordering opens.
The first email should arrive within a minute. Do not see it? Check spam or promotions.
Tell us where to send it
Free, no spam, only peptide news that matters. Unsubscribe anytime.
Why two receptor signals are used
Sermorelin mimics growth-hormone-releasing hormone. GHRP-2 acts through the ghrelin receptor. Human studies show that each pathway can release growth hormone, which supplies the biological rationale for pairing them. Sources: Sermorelin clinical review, GHRP-2 human hormone study
The role assigned to each component
- Sermorelin. Treated as the releasing-hormone foundation for a pituitary pulse.
- GHRP-2. Added as the second signal and often chosen when appetite stimulation is acceptable or desired.
GHRP-2 vs GHRP-6
Both are six-amino-acid ghrelin-receptor agonists that trigger growth-hormone release. GHRP-2 was developed as a more potent analog of GHRP-6. Reported-practice comparisons usually position GHRP-2 for stronger growth-hormone release and GHRP-6 when appetite stimulation is the goal. Human trials have not tested that practical ranking head to head. A controlled study found that GHRP-2 itself increased food intake. Neither peptide should be treated as appetite neutral. Sources: GHRP-2 human hormone study, GHRP-6 human stimulation study, Reported-practice comparison, GHRP-2 food-intake study
How reported schedules are organized
One clinic guide reports 200 mcg of sermorelin with 100 to 200 mcg of GHRP-2 at bedtime for three to six months. A retrospective report documented a different pattern, 100 mcg each of sermorelin, GHRP-2, and GHRP-6 three times daily. These are sourced examples of reported practice, not Rite Aid dosing instructions. Sources: Clinic practice guide, Retrospective secretagogue report
Why sleep enters the discussion
Bedtime-centered clinic descriptions try to align a short-acting injection with overnight growth-hormone physiology. The published multi-dose report shows that bedtime is not a uniform feature of documented practice, so timing depends on the protocol being described. Sources: Clinic practice guide, Retrospective secretagogue report
Side effects and monitoring questions
Small human experiments found that GHRP-2 increased food intake and produced short-term prolactin, ACTH, and cortisol responses. Those findings make appetite changes and hormone-related symptoms more relevant when the compound is discussed. Sources: GHRP-2 food-intake study, GHRP-2 hormone-response study
What remains uncertain about the combination
Human studies support short-term hormone release, but they do not establish sleep, recovery, muscle, fat-loss, or healthy-aging outcomes for the pair. Long-term combination safety and an outcome-based dosage remain unsettled.
Related
Sources
Get the Free Peptide Tracking Toolkit
Sermorelin + GHRP-2 + many more
Explore the guide, then keep the details you verify in the Excel workbook.
Excel workbook
11 worksheets for vials, schedules, labs, storage, and more.
PDF guide
Review providers, products, documents, storage, and travel.
Free download
Useful before or after you start
- Before you start, compare the details that matter and build a focused question list.
- Already using peptides? Keep vials, administration, sites, wellness notes, labs, storage, and travel together.
- Separate your schedule from what actually happened, so important dates are easier to spot.
- Keep your private working copy on your own device.
Confirm your email to receive both downloads and your personal 20% off coupon.
Almost done
We sent the first email to .
Confirm your email to get the toolkit and your 20% off coupon.
We also sent a verification text. Reply YES to confirm your phone number.
-
1
Confirm your email
Open the first email and click the confirmation link.
-
2
Only after step 1
Then the toolkit arrives
We email your Excel workbook and PDF guide right away. Your personal 20% off coupon follows when ordering opens.
The first email should arrive within a minute. Do not see it? Check spam or promotions.
Tell us where to send it
Free, no spam, only peptide news that matters. Unsubscribe anytime.
For general education only — not medical advice or a treatment recommendation. Peptides are not a substitute for care from a licensed provider. Talk to a qualified healthcare professional before you start, stop, or change any peptide, medication, or supplement.
FAQ
Both act at the ghrelin receptor. GHRP-2 is more often associated with appetite and changes in cortisol or prolactin, while ipamorelin is described as more selective.
Bedtime-centered protocols try to align a short-acting injection with overnight growth-hormone physiology, although documented practice also includes multi-dose schedules.